Objective
The purpose of this study was to compare costs for end of life
care in NSCLC patients in Ontario, Canada, and in
Surveillance, Epidemiology and End Results (SEER)
areas, representing 14% of the United States.
This study will advance methods for international comparisons using
administrative data to study the costs of end-of-life care in cancer.